Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients?

Anti-tumor necrosis factor (TNF) therapy is used for the induction and maintenance of remission in Crohn’s disease (CD) patients. However, primary nonresponders to initial treatment constitute 20%–40% of cases. The causes of this phenomenon are still unknown. In this study, we aimed to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Walczak, Michal, Lykowska-Szuber, Liliana, Plucinska, Marianna, Stawczyk-Eder, Kamila, Zakerska-Banaszak, Oliwia, Eder, Piotr, Krela-Kazmierczak, Iwona, Michalak, Michal, Zywicki, Marek, Karlowski, Wojciech M., Szalata, Marlena, Dobrowolska, Agnieszka, Slomski, Ryszard, Skrzypczak-Zielinska, Marzena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456829/
https://www.ncbi.nlm.nih.gov/pubmed/32922288
http://dx.doi.org/10.3389/fphar.2020.01207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456829/
https://www.ncbi.nlm.nih.gov/pubmed/32922288
http://dx.doi.org/10.3389/fphar.2020.01207

Ejemplares similares